SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001558370-23-003721
Filing Date
2023-03-14
Accepted
2023-03-14 16:30:48
Documents
5
Effectiveness Date
2023-03-14

Document Format Files

Seq Description Document Type Size
1 S-8 tmb-20230314xs8.htm S-8 67895
2 EX-5.1 tmb-20230314xex5d1.htm EX-5.1 12191
3 EX-23.1 tmb-20230314xex23d1.htm EX-23.1 2293
4 EX-FILING FEES tmb-20230314xexfilingfees.htm EX-FILING FEES 26862
5 GRAPHIC tmb-20230314xex5d1001.jpg GRAPHIC 4143
  Complete submission text file 0001558370-23-003721.txt   116118
Mailing Address 100 BINNEY STREET STE 600 CAMBRIDGE MA 02142
Business Address 100 BINNEY STREET STE 600 CAMBRIDGE MA 02142 617-336-7540
Sigilon Therapeutics, Inc. (Filer) CIK: 0001821323 (see all company filings)

IRS No.: 474005543 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-270528 | Film No.: 23731476
SIC: 2834 Pharmaceutical Preparations